Celiac Disease Clinical Trials and Celiac Disease Research Studies

I’ve written about the importance of clinical trials in celiac disease research before. Clinical trials are absolutely necessary for the future of celiac disease research and the future of pharmaceutical developments. Several pharmaceutical companies are in late-stage clinical trials that are in need of people with celiac disease to participate. We all need your help.

Please see if you’re eligible for any of the following clinical trials near you!

Solutions for Celiac

The Solutions for Celiac is sponsored by ImmunogenX. It’s a study medication is designed to reduce symptoms of accidental gluten exposure while on a gluten-free diet. The study will include travel to the study site for up to six months.

Solutions for Celiac Product

Latiglutenase – to degrade gluten proteins in the digestive system to make them inactive. The study is investigating a drink that you can take with meals to help digest gluten for accidental exposures.

Solutions for Celiac Qualifications

  • 18-80 years old
  • Biopsy confirmed celiac disease diagnosis
  • Have been on a gluten-free diet for at least 12 months
  • Experienced at least one self-reported moderate or greater severity symptom during the last 28 day period
  • Not pregnant or looking to be pregnant
  • No history of drug or alcohol abuse
  • Locations: Chattanooga, TN (Clinsearch), Chesterfield/Detroit, MI (Clinical Research Institute of Michigan), New York, NY (Columbia University), and Rochester, MN (Mayo Clinic) and soon Boston, MA (Beth Israel Deaconess Medical Center), Palo Alto, CA (Stanford), and Chicago, IL (University of Chicago).
Solutions for Celiac logo

CeDLara Study

The CeDLara study is sponsored by 9 Meters Biopharma. It’s currently in phase 3 clinical trials. The study is about 30 weeks and requires 8 visits to the study center. There are many research sites involved across the US. The study includes a capsule taken by mouth three times a day.

Sign up to be a part of the CeDLara research study now, or email joinstudy@9meters.com.

No gluten challenge required.

CeDLara Study Product

Larazotide acetate – for use with a gluten-free diet in reducing symptoms on a gluten-free diet.

CeDLara Study Qualifications

  • 18+ years of age
  • Biopsy confirmed celiac disease diagnosis
  • Actively experiencing symptoms related to celiac disease (ex. abdominal pain, abdominal cramping, bloating or gas)
  • Diagnosed with celiac more than 6 months ago.
  • Have been on a gluten-free diet for at least 6 months

PROACTIVE Celiac Study

The PROACTIVE celiac study, by Provention Bio Inc., is currently in phase two clinical trials. The study will last about 9 months. There are several clinical sites throughout the US.

See if you qualify for the PROACTIVE study or email info@proactiveceliac.com for any questions.

No gluten challenge required.

PROACTIVE Study Product

PRV-015 is an antibody designed to block an immune system protein called interleukin 15 (IL-15) that causes intestinal inflammation in those with celiac disease. It is for use with a gluten-free diet to reduce symptoms and inflammation caused by accidental gluten exposure.

PROACTIVE Study Qualifications

  • 18-70 years old
  • Biopsy confirmed celiac disease diagnosis
  • On a gluten-free diet for at least the last 12 months
  • Still experiencing celiac disease symptoms

Additional Celiac Disease Clinical Trials

Pay It Forward

I can’t stress how important clinical trials for celiac diseases are to those who have celiac disease – not only for this generation, but the next. Help contribute to celiac disease research and pay it forward to the next generation!

Tagged: , , ,

Leave a Reply

Your email address will not be published. Required fields are marked *